Paper Title
A SINGLE BLIND CLINICAL TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF COMPOUND UNANI FORMULATION IN MANAGEMENT OF DAUS' SADAF (PSORIASIS)
Article Identifiers
: Keywords
Key words:- Koebner phenomenon, Auspitz’s sign, Quath-e-Muddabir-e-Badan, Sitta Zarooria.
Abstract
ABSTRACT Background and Objective: Daus ’Sadaf / Taqashur-e-jild, Psoriasis is one the common diseases of the skin, It is characterized by having sharply demarcated scaly red, coin-sized skin lesions most often on the elbows, knees, scalp, hands and feet. Symptoms include itching, irritation, stinging and pain. Signs to diagnose psoriasis are Koebner phenomenon and Auspitz’s sign, there are two key factors which play a important role in Aetiology of psoriasis, 1. Autoimmune: - Naïve t cells, il12 & il23, 2. Genetic factors: - family history found Up to 30%. However, the Daus ’Sadaf commonly developed for those who has loosed their body immunity or Quath-e-Muddabir-e-Badan (Defensive Mechanism) due to abnormal maintenance of "Sitta Zarooria" many caused alternate the Tabiyath (immunity) and abnormal changes will take place in the humorous and temperament. In Unani concept their might be accumulation of abnormal Sauda and Safra Mutahirqa (Jala huwa safra) into the skin, Hence the objective of the study is to Relief nature of the disease through Unani medicine. Methods: - The study was designed as A Single Blind clinical trail with a sample size 40 patients Joshanda:-21 days Beeq-e-azkhar, Beeq-e- badiyan, Beeq-e-kibr, Beeq-e-karafs, Beeq-e-Kasni, Charaita, Shahitra, Aftimoon, Bisfaij, each 5 grams (OD Dose Before meals 21 days) • Musafiyat:-30 days 1. Qurs-e-sartaan kafoori, one tab BD (after food) 2. Arq-e-murakab musafi khoon, 60ml BD (after food) • Zimad Drugs (Local application): During whole duration of treatment. Ashaq 5 grams, Muqil-e-arzaq 5 grams, Zarvand mudharij 5 grams, Roghan-e-gul 20 ml, Moom-e-zard 20 grams Apply Zimad for a period of (51) days and response of treatment observed, First follow up after using 21 days joshanda (decoction) and then follow up for every 15 days and noted in the case sheets. Similarly, the treatment and response of the lesions measured by PASI Score and Data Analyzed statically. Result: - In this present clinical study of psoriasis, the maximum response out of (40) cases, (24) patients i.e. 60% patients got good response, the satisfactory patients were (10) i.e. 25% and poor response patients were (6) i.e. 15%. P value is <0.0001*. Interpretation and Conclusion: - The study revealed that usage of this Unani medicine got good response in decreasing the sign and symptoms of psoriasis like redness, thickness, itching, and scales. No clinically significant side effects were observed in this study; these results conclude that the drugs used in this study are easily available, safe and effective. Keywords: - Koebner phenomenon, Auspitz’s sign, Quath-e-Muddabir-e-Badan, Sitta Zarooria.
Downloads
How To Cite (APA)
DR. SYED SOFIAN AHMED , DR. MOHAMMED AHSAN FAROQUI , & DR. ABDUL LATEEF SIDDIQUI (February-2024). A SINGLE BLIND CLINICAL TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF COMPOUND UNANI FORMULATION IN MANAGEMENT OF DAUS' SADAF (PSORIASIS). INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 9(2), c399-c417. https://ijnrd.org/papers/IJNRD2402247.pdf
Issue
Volume 9 Issue 2, February-2024
Pages : c399-c417
Other Publication Details
Paper Reg. ID: IJNRD_214319
Published Paper Id: IJNRD2402247
Downloads: 000122254
Research Area: Medical Science
Author Type: Indian Author
Country: HYDERABAD, Telangana, India
Published Paper PDF: https://ijnrd.org/papers/IJNRD2402247.pdf
Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2402247
About Publisher
Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)
UGC CARE JOURNAL PUBLICATION | ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG
Copyright & License
© 2025 — Authors hold the copyright of this article. This work is licensed under a Creative Commons Attribution 4.0 International License. and The Open Definition.
You are free to share, adapt, and redistribute the material, provided proper credit is given to the original author. 🛡️ Disclaimer: The content, data, and findings in this article are based on the authors’ research and have been peer-reviewed for academic purposes only. Readers are advised to verify all information before practical or commercial use. The journal and its editorial board are not liable for any errors, losses, or consequences arising from its use.
Publication Timeline
Article Preview: View Full Paper
Call For Paper
IJNRD is a Scholarly Open Access, Peer-Reviewed, Refereed, and UGC CARE Journal Publication with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost, and Transparent Peer Review Journal Publication that adheres to the UGC CARE 2025 Peer-Reviewed Journal Policy and aligns with Scopus Journal Publication standards to ensure the highest level of research quality and credibility.
IJNRD offers comprehensive Journal Publication Services including indexing in all major databases and metadata repositories, Digital Object Identifier (Crossref DOI) assignment for each published article with additional fees, citation generation tools, and full Open Access visibility to enhance global research reach and citation impact.
The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse academic and professional fields. The journal promotes global knowledge exchange among researchers, developers, academicians, engineers, and practitioners, serving as a trusted platform for innovative, peer-reviewed journal publication and scientific collaboration.
Indexing Coverage: Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many other recognized academic repositories.
How to submit the paper?
By Our website
Click Here to Submit Paper Online
You can now publish your research in IJNRD. IJNRD is a Transparent Peer-Reviewed Open Access Journal Publication (Refereed Journal), aligning with New UGC and UGC CARE recommendations.
For more details, refer to the official notice: UGC Public Notice
Submit Paper Online
Important Dates for Current issue
Paper Submission Open For: December 2025
Current Issue: Volume 10 | Issue 12 | December 2025
Impact Factor: 8.76
Last Date for Paper Submission: Till 31-Dec-2025
Notification of Review Result: Within 1-2 Days after Submitting paper.
Publication of Paper: Within 01-02 Days after Submititng documents.
Frequency: Monthly (12 issue Annually).
Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.
Subject Category: Research Area
Call for Paper: More Details
Approval, Licenses and Indexing: More Details
